Business Wire

Bausch + Lomb Will Acquire XIIDRA®

Acquisition Represents Significant Opportunity for Growth in Prescription Dry Eye SegmentVAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live bet

More

Cybin to Participate in PSYCH Symposium London 2023

- Cybin’s Chief Medical Officer Amir Inamdar to participate in a fireside chat on July 6, 2023 -TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committe

More